M-M-R II is a vaccine used to help protect people from getting measles, mumps and rubella (German measles).
M-M-R II is now approved for two routes of administration: subcutaneous and intramuscular (IM) injections. The product information has been updated to include text on IM administration in the relevant sections. The updated product information and the consumer medicine information are available on the Therapeutic Goods Administration website and also via the digital Australian immunisation Handbook.
The recommendations about administration will be updated in the digital Australian Immunisation Handbook soon.
Learn more via HealthPathways:
For a list of all localised pathways see:
Mid and North Coast Localised Pathways
Username:Â manchealth
Password:Â conn3ct3d
For further information about HealthPathways email [email protected] or [email protected].